Tianda Pharmaceuticals (HKSE:00455) EV-to-Revenue : 0.89 (As of May. 25, 2024)

View and export this data going back to 1992. Start your Free Trial

What is Tianda Pharmaceuticals EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Tianda Pharmaceuticals's enterprise value is HK$471.5 Mil. Tianda Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$532.1 Mil. Therefore, Tianda Pharmaceuticals's EV-to-Revenue for today is 0.89.

The historical rank and industry rank for Tianda Pharmaceuticals's EV-to-Revenue or its related term are showing as below:

HKSE:00455' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.13 Med: 0.96 Max: 5.18
Current: 0.89

During the past 13 years, the highest EV-to-Revenue of Tianda Pharmaceuticals was 5.18. The lowest was -0.13. And the median was 0.96.

HKSE:00455's EV-to-Revenue is ranked better than
82.23% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 2.285 vs HKSE:00455: 0.89

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-25), Tianda Pharmaceuticals's stock price is HK$0.242. Tianda Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.25. Therefore, Tianda Pharmaceuticals's PS Ratio for today is 0.98.

Tianda Pharmaceuticals EV-to-Revenue Historical Data

The historical data trend for Tianda Pharmaceuticals's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianda Pharmaceuticals EV-to-Revenue Chart

Tianda Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

0.20

0.80

0.68

0.79

Tianda Pharmaceuticals Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Jun23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															-	0.68	-	-	0.79

Competitive Comparison of Tianda Pharmaceuticals's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Tianda Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tianda Pharmaceuticals's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianda Pharmaceuticals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Tianda Pharmaceuticals's EV-to-Revenue falls into.

Tianda Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Tianda Pharmaceuticals's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	471.465	/	532.089
	=	0.89

Tianda Pharmaceuticals's current Enterprise Value is HK$471.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Tianda Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$532.1 Mil.

Tianda Pharmaceuticals (HKSE:00455) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Tianda Pharmaceuticals's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.242	/	0.247
	=	0.98

Tianda Pharmaceuticals's share price for today is HK$0.242.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.25.

Tianda Pharmaceuticals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Tianda Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Tianda Pharmaceuticals (HKSE:00455) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianda Pharmaceuticals Ltd (HKSE:00455) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

CITIC Tower, No. 1 Tim Mei Avenue, Suites 2405-2410, 24th Floor, Central, Hong Kong, HKG

Website

https://www.tiandapharma.com

Tianda Pharmaceuticals Ltd is engaged in R&D, manufactures and sales of pharmaceutical, biotechnology and healthcare products. The group also engages in R&D of Chinese medicine and manufacture and sales of Chinese medicine products, and the provision of Chinese medical services. Its operating segments include Chinese medicine business; Medical and healthcare services; and Pharmaceuticals and medical technologies business. The company derives majority of the revenue from Pharmaceuticals and medical technologies business.

Executives

Tianda Group Limited	2101 Beneficial owner
Fang Wen Quan	2201 Interest of corporation controlled by you

Tianda Pharmaceuticals (HKSE:00455) Headlines

No Headlines